Cyltezo, adalimumab biosimilar from Boehringer Ingelheim, approved in E
The European Commission has granted marketing authorisation for a biosimilar...
2017-11-15
文传商讯
Boehringer Ingelheim and Dicerna Announce Collaboration to Develop Nove
Dicerna to receive up to $201 million in upfront and success-based developme...
2017-11-06
文传商讯
Boehringer Ingelheim receives positive CHMP opinion for adalimumab bios
Committee for Medicinal Products for Human Use (CHMP) of the European Medici...
2017-09-19
文传商讯
Boehringer Ingelheim Phase III study now enrolling patients with progre
For the first time, patients with different fibrosing lung diseases will be ...
2017-03-22
文传商讯
